<p>Scinai Immunotherapeutics 将在第七届欧洲皮肤病药物开发峰会上主导关于口服疗法和生物制剂未来的战略圆桌讨论 | SCNI 股票新闻</p>

SCNI

纽交所高增长板生物技术指数 ETF - First Trust

2 倍做多纳斯达克生物技术 ETF - ProShares

动态生物技术与基因组 ETF - Invesco

IBBQ

生物科技 ETF - VanEck Vectors

标普生物技术 ETF - SPDR

标普生物技术 3 倍做多 - Direxion

医药突破 ETF - ALPS

纳斯达克生物科技指数 ETF - iShares Nasdaq

<p>Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe | SCNI Stock News</p>
<div class="lb-trans"><p>Scinai Immunotherapeutics 将在第七届欧洲皮肤病药物开发峰会上主导关于口服疗法和生物制剂未来的战略圆桌讨论 | SCNI 股票新闻</p>
</div>

Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe | SCNI Stock News

StockTitan

Scinai Immunotherapeutics

Invesco Nasdaq Biotechnology ETF

Scinai Immunotherapeutics 将在第七届欧洲皮肤病药物开发峰会上领导关于口服疗法和生物制剂未来的战略圆桌讨论 | SCNI 股票新闻